Simulations Plus (NASDAQ:SLP) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Simulations Plus (NASDAQ:SLP) issued its earnings results on Thursday. The technology company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.07, FiscalAI reports. The business had revenue of $21.89 million during the quarter, compared to the consensus estimate of $20.90 million. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.

Simulations Plus Price Performance

Shares of NASDAQ:SLP traded up $0.07 during trading on Thursday, reaching $18.34. 378,542 shares of the stock were exchanged, compared to its average volume of 387,888. Simulations Plus has a 1-year low of $11.09 and a 1-year high of $21.01. The stock has a fifty day moving average of $16.40 and a two-hundred day moving average of $15.48. The firm has a market cap of $370.47 million, a price-to-earnings ratio of -5.86 and a beta of 1.30.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. TD Cowen reduced their price objective on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Craig Hallum downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price on the stock. in a research report on Thursday, June 18th. Wall Street Zen lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. William Blair lowered shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. Finally, Weiss Ratings upgraded shares of Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, June 5th. One equities research analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $19.88.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 4,177 shares of Simulations Plus stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total value of $77,023.88. Following the completion of the sale, the director owned 3,202,131 shares of the company’s stock, valued at approximately $59,047,295.64. This trade represents a 0.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 6,177 shares of company stock valued at $108,754. Company insiders own 19.10% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after buying an additional 390 shares during the last quarter. Deutsche Bank AG lifted its position in Simulations Plus by 5.9% in the 4th quarter. Deutsche Bank AG now owns 15,825 shares of the technology company’s stock valued at $288,000 after acquiring an additional 875 shares in the last quarter. Prudential Financial Inc. lifted its position in Simulations Plus by 5.7% in the 2nd quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock valued at $300,000 after acquiring an additional 930 shares in the last quarter. Invesco Ltd. boosted its stake in Simulations Plus by 3.8% during the 2nd quarter. Invesco Ltd. now owns 36,452 shares of the technology company’s stock valued at $636,000 after purchasing an additional 1,323 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in Simulations Plus during the 2nd quarter valued at about $25,000. 78.08% of the stock is owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.